Note: This is a redacted case example of where Nooma supported a senior pharma leader during her transition. Frieda is a well- respected clinical operations
Over the last 30 years, size, scale and complexity of clinical trials has increased. Headcount, in terms of the number of people working on trials
Raul had just been designated Global Process Owner for informed consent (ICF). Because Raul was known as a competent leader with a deep internal network,
Francheska’s brow furrowed as she looked at this quarter’s operational metrics. Her lips pursed with annoyance, “Every month I’m getting requests for more headcount, more
©2022 Nooma Group | All Rights Reserved